Thrivent Financial for Lutherans’s Adaptive Biotechnologies ADPT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$593K	Hold	27,670	–	–	﹤0.01%	2243
2026 Q1	$384K	Sell	27,670 -10,264	-27%	-$164K	﹤0.01%	2302
2025 Q4	$618K	Buy	+37,934	New	+$619K	﹤0.01%	2169
2023 Q3	–	Sell	-42,435	Closed	-$285K	–	2429
2023 Q2	$285K	Sell	42,435 -2,082	-5%	-$15.5K	﹤0.01%	2335
2023 Q1	$393K	Sell	44,517 -248,226	-85%	-$2.19M	﹤0.01%	2217
2022 Q4	$2.24M	Buy	292,743 +4,196	+1%	+$32.6K	0.01%	1183
2022 Q3	$2.05M	Buy	288,547 +13,787	+5%	+$130K	0.01%	1200
2022 Q2	$2.22M	Sell	274,760 -18,196	-6%	-$160K	0.01%	1174
2022 Q1	$4.07M	Sell	292,956 -294,814	-50%	-$4.64M	0.01%	962
2021 Q4	$16.5M	Buy	587,770 +24,508	+4%	+$751K	0.03%	524
2021 Q3	$19.1M	Buy	563,262 +14,086	+3%	+$509K	0.04%	476
2021 Q2	$22.4M	Buy	549,176 +111,051	+25%	+$4.32M	0.05%	426
2021 Q1	$17.6M	Buy	+438,125	New	+$23.7M	0.04%	483
2020 Q4	–	Hold	0	–	–	–	2153

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Thrivent Financial for Lutherans's ADPT Position: Q2 2026 in Review

Thrivent Financial for Lutherans held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 27,670 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Thrivent Financial for Lutherans first reported a position in ADPT in Q1 2021 and has held it in 13 quarters since. The position peaked at $22.4M in Q2 2021. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Thrivent Financial for Lutherans held 27,670 shares of Adaptive Biotechnologies worth $593K as of Q2 2026.
Thrivent Financial for Lutherans left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2243 holding.
Thrivent Financial for Lutherans first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 13 quarters since.
Thrivent Financial for Lutherans's Adaptive Biotechnologies position peaked at $22.4M in Q2 2021.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.